ASOthera Pharmaceuticals' Debt Round

ASOthera Pharmaceuticals raised a round of funding on November 24, 2014.

ASOthera Pharmaceuticals is developing antisense-oligonucleotide therapeutics for the treatment of genetic diseases.…

Articles about ASOthera Pharmaceuticals' Debt Round: